Gaudium IVF and Women Health Limited Announces Q3 & 9M FY26 Financial Results
New Delhi, March 19, 2026 — Gaudium IVF and Women Health Limited, a leading fertility and women's healthcare platform in India, announced its unaudited financial results for the quarter and nine months ended December 31, 2025, on March 18, 2026. The results mark the company’s first earnings announcement following its recent listing.Financial Performance
For the quarter ended December 31, 2025 (Q3 FY26):| Amount (₹ lakh) | |
|---|---|
| Revenue from operations | 2,450.70 |
| Total income | 2,461.00 |
| Profit before tax (PBT) | 496.31 |
| Net profit | 363.05 |
For the nine months ended December 31, 2025 (9M FY26):
| Amount (₹ lakh) | |
|---|---|
| Revenue from operations | 7,400.58 |
| Total income | 7,435.97 |
| Profit before tax (PBT) | 2,174.59 |
| Net profit | 1,614.90 |
The company maintained healthy margins during the period, supported by operating leverage and disciplined cost management.
Key Business Highlights
Gaudium IVF completed its Initial Public Offering (IPO), raising approximately ₹16,500.098 lakh, followed by its listing on the National Stock Exchange of India Limited and BSE Limited on February 27, 2026.Dr. Manika Khanna, Chairperson and Managing Director, Gaudium IVF and Women Health Limited, stated that the results reflect a category that is coming of age and that Gaudium IVF is at the forefront of shaping it. She emphasized the company's commitment to expanding access, deepening outcomes, and building India's most trusted and outcome-driven fertility network.
Gaudium IVF and Women Health Limited operates a network of fertility centres across Delhi, Mumbai, Bangalore, Patna, Ludhiana, and Srinagar, providing a comprehensive suite of services, including IVF, ICSI, IUI, fertility preservation, infertility treatments, advanced genetic testing, high-risk pregnancy care, and minimally invasive gynecological procedures.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.